RNS Number : 3799F
AIM
30 October 2025
NOTICE
30/10/2025 - 08:00
The London Stock Exchange admits the following securities to trading on AIM:
Allergy Therapeutics Plc
1,375,000,000
ORDINARY SHARES OF 0.1P EACH, FULLY PAID
(B02LCQ0)(GB00B02LCQ05)
Bezant Resources Plc
72,000,000
ORDINARY SHARES OF 0.002P EACH, FULLY PAID
(B1CKQD9)(GB00B1CKQD97)
GENEDRIVE PLC
4,708,584
ORDINARY SHARES OF 0.015P EACH, FULLY PAID
(B1VKB24)(GB00B1VKB244)
Landore Resources Limited
35,515,151
ORDINARY SHARES OF NO PAR VALUE, FULLY PAID
(BMX4VR6)(GG00BMX4VR69)
Metals Exploration Plc
173,681
ORDINARY SHARES OF GBP0.0001 EACH
(B0394F6)(GB00B0394F60)
Newmark Security Plc
20,000
ORDINARY SHARES OF GBP0.05 EACH, FULLY PAID
(BNYM9W7)(GB00BNYM9W73)
One Health Group plc
21,885
ORDINARY SHARES OF 0.5P EACH, FULLY PAID
(BNNT059)(GB00BNNT0595)
Touchstone Exploration Inc
63,636,363
COMMON SHARES OF NO PAR VALUE FULLY PAID (DI)
(BD8ZCD4)(CA89156L1085)
Vast Resources Plc
529,027,778
ORDINARY SHARES OF 0.1P EACH, FULLY PAID
(BQ7WTT2)(GB00BQ7WTT20)
If you have any queries or require further information, please contact Market Operations on 020 7797 4310.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
AMOBLBDGCDDDGUC
